Innoviva (United States)

Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study

Lauren C. Tantalo, Nicole A. P. Lieberman, Clara Pérez‐Mañá et al. · The Lancet Microbe · 2023 · 52 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of<i>Acinetobacter baumannii</i>

Samir H. Moussa, Adam B. Shapiro, Sarah M. McLeod et al. · Antimicrobial Agents and Chemotherapy · 2023 · 45 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock

Daniel E. Leisman, Damian Handisides, Laurence W. Busse et al. · Critical Care · 2024 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial

Alison Luckey, Manica Balasegaram, Lindley A. Barbee et al. · The Lancet · 2025 · 29 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock

Daniel E. Leisman, Damian Handisides, Lakhmir S. Chawla et al. · Annals of Intensive Care · 2023 · 22 citations · Full text

Medicine, Pharmacotherapy, Hemodynamic Management +16